737max

U.S. stocks rose across the board yesterday, but Boeing plunged against the trend—the sell-off wasn’t an emotional overreaction, but a repricing of a “recovery timeline pushed further out.”

At the close of U.S. trading on October 27, Boeing stood at $168.18, down $20.13 (-10.69%) for the day, from a previous close of $188.31. Its intraday low was about $167.41, the lowest since April 2025. Trading volume was about 46.8 million shares, nearly seven times the three-month average of 6.8 million—clearly, this wasn’t retail investors doing the selling. On the same day, the S&P 500 rose 0.60% and the Nasdaq gained 1.18%. Boeing underperformed the broader market by about 11 percentage points, making it the most striking contrast among large-cap stocks that day.

The earnings report itself was “better, but not good enough.” Third-quarter revenue was $24.188 billion, up 4% year over year. GAAP net loss was $116 million, or $0.26 per share—significantly narrower than the $5.34 billion loss a year earlier. Operating cash flow was $1.5 billion and free cash flow about $500 million, so the company is indeed recovering financially. But the market focused on the key figures: non-GAAP core loss per share was $0.34, worse than the expected loss of about $0.24–$0.25, while revenue also came in slightly below expectations. For a company still telling a turnaround story, that was enough to send the stock lower.

What really prompted investors to sell hard was the segment mix and deliveries. Commercial Airplanes generated $10.72 billion in revenue, down 3% year over year, with an operating loss of $697 million and a -6.5% margin. Third-quarter deliveries totaled 161 aircraft, up just 1% year over year. An unfavorable delivery mix, along with higher estimates for supply-chain costs and the future costs of ramping up production, ate into profits. By contrast, Defense revenue was $7.94 billion, up 15% year over year, with a 6.2% margin; Services revenue was $5.57 billion, up 4%, with an 18.3% margin. Improvement is coming from defense and services; commercial aircraft is the drag. The company also acknowledged that it will miss its full-year target of delivering 500 737 MAX aircraft, and that production is ramping up more slowly than hoped—effectively pushing the earnings inflection point further out.

My view: this isn’t “Boeing is in trouble again”; it’s “the recovery trajectory has been marked down.” The foundation hasn’t collapsed: Boeing has a record $745 billion backlog, including more than 6,300 commercial aircraft. The 737-7 and 737-10 received FAA certification in October, and in September the company secured a roughly $20 billion Navy next-generation F/A-XX fighter program. Cash flow has also turned positive. So this sharp drop looks more like a double hit to valuation and expectations than a collapse in fundamentals.

The risks are worth spelling out: if deliveries don’t ramp up in the fourth quarter and commercial aircraft margins still fail to improve, -10.69% may not be the bottom. We’ve already seen the kind of scenario where “good news comes out, only for the earnings report to wipe it out” play out last year. Conversely, the key things to watch for a potential entry aren’t the quarterly loss figures, but whether deliveries, the production ramp-up, and commercial aircraft margins all improve at the same time. The backlog provides a basis for a rebound, but only deliveries can turn it into profit.

Personal research; not investment advice.
$BA
#波音 #737MAX #美股财报 #Aerospace